Compelo Medical Devices - Latest industry news and analysis is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

Lumenis showcases advanced CO2 solutions for throat cancer

Lumenis, the world's largest energy-based medical company for surgical, ophthalmology and aesthetic applications, showcases its novel CO2 laser AcuPulse DUO, along with a wide range of fibers and accessories, at the Academy of Otolaryngology - Head and Neck Surgery (AAO-HNSF) 2014 Annual Meeting, which takes place September 21-24th in Orlando, Florida. Lumenis exhibits at booth #829 throughout the meeting.

Tzipi Ozer-Armon, CEO of Lumenis, stated: "Our commitment to delivering the advanced and versatile ENT solutions for physicians and patients was the driving force behind the development of the AcuPulse DUO, our flagship platform for head and neck surgery.

This advanced product solution perfectly embodies our mission of brininging better technologies for better patient care in the ENT domain. I am also pleased to say that thus far we have received outstanding feedback from surgeons regarding the performance of the AcuPulse DUO. Furthermore, as evident from mounting clinical data, this product significantly improves access to transoral laser microsurgery, or TLM, which can help preserve throat cancer patients’ facial appearance and protect the ability to function normally."
Throat cancer is the second most common cancer in the upper aerodigestive tract, with over 12,000 new cases a year in the United States and nearly 3,000 annual deaths.1 The use of chemotherapy, radiation therapy, or cold knife surgery in the treatment of transoral airway cancer is associated with complications.

Alternatively, TLM offers low morbidity and excellent cure rates compared to chemoradiation.2 Patients treated with TLM have no risk of radiation-associated side effects. Overall treatment and recovery time are faster than with radiation. Moreover, after receiving radiation as the first-line treatment, many patients may no longer be able to undergo minimally invasive procedures if the first round of radiation therapy is unsuccessful. The only option then is radical surgery, often requiring removal of the whole voice box, resulting in loss of voice. With TLM, the option of repeated minimally invasive surgery interventions and even radiation therapy remains, if necessary.

AcuPulse DUO has a wide range of fibers and accessories that are tailored to patient needs and enhance surgeons’ flexibility, and surgical capabilities to treat a broader range of clinical applications. The innovative MicroLase Fiber with Micro-G and Micro-H Otology Kits significantly reduce the cost per procedure since the fiber can be used up to 25 times and offers disposable tips. The superior design of the fiber allows sufficient laser energy transmission, enabling to get as close as possible to parity between the energy displayed on screen and the energy actually delivered to the patient.

Lumenis’ uncompromising commitment to improving the health and well-being of patients has led to the expansion of its technology outside the operating room and into outpatient treatment. With a strong emphasis on efficacy, patients can now get affordable yet personalized treatments without down time under local anesthesia.